1. Woolcock PR. Duck hepatitis. In Diseases of Poultry, 11th ed. Saif YM, Barnes HJ, Glisson JR, Fadly AM, McDougald LR, Swayne DE, Eds.; Iowa State University Press: Ames, IA, USA, 2003; pp: 343–54.
2. Kim M, Kim M, Kwon Y, Lindberg A, Joh S, Kwon H, et al. Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections. Vaccine. 2009; 27(48): 6688-94.
3. Tseng C, Knowles N, Tsai H. Molecular analysis of duck hepatitis virus type 1 indicates that it should be assigned to a new genus. Virus Res. 2007; 123(2): 190-203.
4. Tseng C, Tsai H. Molecular characterization of a new serotype of duck hepatitis virus. Virus Res. 2007; 126(1-2): 19-31.
5. Fu Y, Pan M, Wang X, Xu Y, Yang H, Zhang D. Molecular detection and typing of duck hepatitis A virus directly from clinical specimens. Vet Microbiol. 2008; 131(3-4): 247-57.
6. Kim M, Kwon Y, Joh S, Kim S, Tolf C, Kim J, et al. Recent Korean isolates of duck hepatitis virus reveal the presence of a new geno- and serotype when compared to duck hepatitis virus type 1 type strains. Arch Virol. 2007; 152(11): 2059-72.
7. Liu M, Fanyi M, Li X, Zhang Z, Liu S, Zhang Y. Goose haemorrhagic hepatitis caused by a new subtype duck hepatitis type 1 virus. Vet Microbiol. 2011; 152(3-4): 280-3.
8. Wei C, Su S, Huang Z, Zhu W, Chen J, Zhao F, et al. Complete genome sequence of a novel duck hepatitis A virus discovered in southern China. J Virol. 2012; 86(18): 10247.
9. Guérin J, Noutary V, Boissieu C, Albaric O, Wyers M. Viral pancreatitis and encephalitis of Muscovy ducklings. Vet Rec. 2005; 157(11): 328.
10. Fu G, Chen H, Huang Y, Shi S. Identification and sequence analysis of duck hepatitis A virus type I isolated from Muscovy duckling with pancreatitis. FJ J Agri Sci. 2012; 27(9): 43-5. (in Chinese)
11. Chen Z, Fu Q, Chen H, Fu G. Different pathogenicity of duck Hepatitis A virus 1 between pancreatitis-type and classical duckling. FJ J Agri Sci. 2013; 28 (10): 939-42. (in Chinese)
12. Fu Q, Chen Z, Huang Y, Fu G. Identification of subtype of duck hepatitis A virus type 1 causing pancreatitis. Chin J Vet Med. 2015; 51(7): 36-8. (in Chinese)
13. Liu R, Shi S, Huang Y, Chen Z, Chen C, Cheng L, et al. Comparative pathogenicity of different subtypes of duck hepatitis A virus in Pekin ducklings. Vet Microbiol. 2019; 228: 181-7.
14. Zhu T, Qi B, Liu R, Jiang X, Lu R, Xiao L, et al. Comparative pathogenicity of two subtypes (hepatitis-type and pancreatitis-type) of duck hepatitis A virus type 1 in experimentally infected Muscovy ducklings. Avian Pathol. 2019; 48(4): 352-61.
15. Hartlova A,Krocova Z,Cerveny L,Stulik J. A proteomic view of the host-pathogen interaction: The host perspective. Proteomics. 2011; 75(1) : 246-56.
16. Cha S, Roh J, Kang M, Kim B, Jang H. Isolation and characterization of a low pathogenic duck hepatitis A virus 3 from South Korea. Vet Microbiol. 2013; 162(1): 254-8.
17. Qian X, Ba Y, Zhuang Q, Zhong G. RNA-Seq technology and its application in fish transcriptomics. OMICS. 2014; 18(2): 98-110.
18. Wang Q, Liu M, Xu L, Wu Y, Huang Y. Transcriptome analysis reveals the molecular mechanism of hepatic fat metabolism disorder caused by Muscovy duck reovirus infection. Avian Pathol. 2018; 47(2): 127-39.
19. Wang X, Zhang J, Meng R, Jiang Y, Liang S, Zhang Y, et al. Host differences affecting resistance and susceptibility of the second generation of a Pekin duck flock to duck hepatitis A virus genotype 3. Front Microbiol. 2017; 8: 1128.
20. Yan L, Qu S, Liu G, Liu L, Yu Y, Ding G, et al. Comparative transcriptomic analysis of primary duck hepatocytes provides insight into differential susceptibility to DHBV infection. PLoS One. 2016; 11(2): e0149702.
21. Zhang X, Cao C, Liu Y, Qi H, Zhang W, Hao C, et al. Comparative liver transcriptome analysis in ducklings infected with duck hepatitis A virus 3 (DHAV-3) at 12 and 48 hours post-infection through RNA-seq. Vet Res. 2018; 49(1): 52.
22. Zhang Q. Research on the transcriptome of DHAV-1 infected duckling’s livers through RNA-Seq. 2013, Huazhong Agricultural University: Wuhan. (in Chinese)
23. Hart C, Race V, Achouri Y, Wiame E, Sharrard M, Olpin S, et al. Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway. Am J Hum Genet. 2007; 80(5): 931-7.
24. El-Hattab A. Serine biosynthesis and transport defects. Mol Genet Metab. 2016; 118(3): 153-9.
25. Zaki M, Thoenes M, Kawalia A, Nurnberg P, Kaiser R, Heller R, et al. Recurrent and prolonged infections in a child with a homozygous IFIH1 nonsense mutation. Front Genet. 2017; 8: 130.
26. Jiang H, Yu Y, Liu S, Zhu M, Dong X, Wu J, et al. Proteomic study of a Parkinson's disease model of undifferentiated SH-SY5Y cells induced by a proteasome inhibitor. Int J Med Sci. 2019; 16(1): 84-92.
27. Sim W, Yin H, Choi H, Choi Y, Kwak H, Kim S, et al. L-serine supplementation attenuates alcoholic fatty liver by enhancing homocysteine metabolism in mice and rats. J Nutr. 2015; 145(2): 260-7.
28. Sun L, Bartlam M, Liu Y, Pang H, Rao Z. Crystal structure of the pyridoxal-5'-phosphate-dependent serine dehydratase from human liver. Protein Sci. 2005; 14(3): 791-8.
29. Talukdar G, Inoue R, Yoshida T, Ishimoto T, Yaku K, Nakagawa T, et al. Novel role of serine racemase in anti-apoptosis and metabolism. Biochim Biophys Acta Gen Subj. 2017; 1861(1): 3378-87.
30. Ogawa H, Gomi T, Fujioka M. Serine hydroxymethyltransferase and threonine aldolase: are they identical? Int J Biochem Cell Biol. 2000; 32(3): 289-301.
31. Cario E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut. 2005; 54(8): 1182-93.
32. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev. 2009; 227(1): 75-86.
33. Aderem A, Ulevitch R. Toll-like receptors in the induction of the innate immune response. Nature. 2000; 406(6797): 782-7.
34. Medzhitov R, Preston-Hurlburt P, Janeway C. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997; 388(6640): 394-7.
35. Dolganiuc A, Oak S, Kodys K, Golenbock D, Finberg R, Kurt-Jones E, et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology. 2004; 127(5): 1513-24.
36. Feldmann G, Nischalke H, Nattermann J, Banas B, Berg T, Teschendorf C, et al. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. Clin Cancer Res. 2006; 12(15): 4491-8.
37. Arbour N, Lorenz E, Schutte B, Zabner J, Kline J, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000; 25(2): 187-91.
38. Lorenz E, Mira J, Frees K, Schwartz D. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med. 2002; 162(9): 1028-32.
39. Qureshi S, Lariviere L, Leveque G, Clermont S, Moore K, Gros P, et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med. 1999; 189(4): 615-25.
40. Kurt-Jones E, Popova L, Kwinn L, Haynes L, Jones L, Tripp R, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000; 1(5): 398-401.
41. Smiley S, King J, Hancock W. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol. 2001; 167(5): 2887-94.
42. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002; 195(1): 99-111.
43. Li F, Li X, Zou G, Gao Y, Ye J. Association between TLR7 copy number variations and hepatitis B virus infection outcome in Chinese (corrected: China). World J Gastroenterol. 2017; 23(9): 1602-7.
44. Horner S. Activation and evasion of antiviral innate immunity by hepatitis C virus. J Mol Biol. 2014; 426(6): 1198-209.
45. Thimme R, Binder M, Bartenschlager R. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. FEMS Microbiol Rev. 2012; 36(3): 663-83.
46. Nazmi A, Mukherjee S, Kundu K, Dutta K, Mahadevan A, Shankar S, et al. TLR7 is a key regulator of innate immunity against Japanese encephalitis virus infection. Neurobiol Dis. 2014; 69: 235-47.
47. Funk E, Kottilil S, Gilliam B, Talwani R. Tickling the TLR7 to cure viral hepatitis. J Transl Med. 2014; 12: 129.
48. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2008; 36: 480-4.
49. Wu J, Mao X, Cai T, Luo J, Wei L. KOBAS server: a web-based platform for automated annotation and pathway identification. Nucleic Acids Res. 2006; 34: 720-4.
50. Cikos S, Bukovska A, Koppel J. Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis. BMC Mol Biol. 2007; 8: 113.